Saccade
Saccade is developing an investigational eye-movement assessment intended to capture data that may serve as a potential biomarker for Alzheimer’s disease. The company is building a platform to administer eye-tracking tests and is currently recruiting individuals living with Alzheimer’s or those with a family history to express interest in future research studies. The assessment is designed to support earlier and more accessible detection methods, though it remains investigational and is not yet validated for diagnosis or individual risk prediction.
- Healthcare Technology
- Digital Health
- Software Only
Funding
Raised to date
$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Founder details are not available yet.
Product
Problem
Alzheimer’s disease diagnosis and risk assessment currently rely on invasive procedures, expensive imaging, or cognitive tests that detect changes only after significant progression. There is a need for accessible, non-invasive biomarkers that can support earlier detection and ongoing research into the disease.
Solution
Saccade is developing an investigational eye-movement assessment designed to capture data that may serve as a potential biomarker for Alzheimer’s disease. The company is building a platform to administer eye-tracking tests and is currently recruiting individuals living with Alzheimer’s or those with a family history to express interest in future research studies. The assessment is intended to support Alzheimer’s research efforts, with the goal of enabling earlier and more accessible detection methods. Saccade emphasizes that the technology remains investigational and is not yet validated for diagnosis, individual risk prediction, or treatment decisions.
Target Audience
Primary audiences are individuals living with Alzheimer’s disease or those with a family history who may participate in future research studies, as well as clinical practices and research institutions interested in supporting Alzheimer’s research.
Features
- Investigational eye-movement assessment technology designed to capture potential biomarkers for Alzheimer’s disease
- Public sign-up system for individuals living with Alzheimer’s or with a family history to express interest in future studies
- Separate inquiry process for clinics interested in participating in the Saccade program
- Optional SMS-based appointment and booking communications for study participants
- Privacy-focused data handling with secure AWS-hosted databases for sign-up and clinic inquiry information